Planet Labs
PL
$43.04
+5.65%
Planet Labs PBC is an Earth-imaging company that operates a large constellation of satellites to capture daily imagery of the globe, providing data, analytics, and insights for commercial, government, and defense applications within the Aerospace & Defense industry. The company is a market leader and disruptor in the geospatial intelligence sector, distinguished by its unique ability to image the entire Earth's landmass daily, creating a foundational data platform. The current investor narrative is intensely focused on the stock's dramatic re-rating, driven by a transformative AI partnership with NVIDIA, a massive new defense contract, and explosive revenue growth reported in March 2026, all of which have fueled a debate about whether the surge is sustainable or partly driven by broader sector sentiment around SpaceX's planned IPO.…
PL
Planet Labs
$43.04
Related headlines
Investment Opinion: Should I buy PL Today?
Rating: Hold. The core thesis is that while Planet Labs exhibits powerful growth and transformative catalysts, its extreme valuation and high volatility create a risk/reward profile that is balanced at current levels, warranting a wait for a better entry point or clearer evidence of sustained profitability.
Supporting evidence includes the accelerating 41% YoY revenue growth, the significant improvement in operating margin from -80.5% to -41.5% YoY, and the generation of positive TTM free cash flow. However, these positives are counterbalanced by a sky-high trailing PS ratio of 24.98x, deep net losses, and a lack of analyst consensus targets to anchor fair value. The stock's 1-year gain of +1001% suggests much of the optimistic narrative is already priced in.
The thesis would upgrade to a Buy if the PS ratio compresses below 15x on sustained growth, or if the company reports consecutive quarters of positive operating income. It would downgrade to a Sell if revenue growth decelerates below 25% or if operating margins deteriorate. Relative to its own history and the implied expectations of flawless execution, the stock is overvalued. It is a compelling story stock, but at this price, it is fairly valued to slightly overvalued for all but the most risk-tolerant growth investors.
Sign up to view all
PL 12-Month Price Forecast
The outlook is bifurcated between a transformative growth story and a valuation air pocket. The base case of consolidation is most likely, given the stock's need to prove it can grow into its premium valuation. The recent fundamental improvements are real, but the price already reflects tremendous success. The stance would upgrade to bullish on a pullback toward the $25-$30 range (near the base case target) or on conclusive evidence of sustained operating margin expansion toward breakeven. It would turn bearish if the next quarterly report shows revenue growth deceleration or increased cash burn.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Planet Labs's 12-month outlook, with a consensus price target around $55.95 and implied upside of +30.0% versus the current price.
Average Target
$55.95
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$34 - $56
Analyst target range
Insufficient analyst coverage available. The provided data indicates only 4 analysts providing EPS and revenue estimates, with no consensus price target, recommendation, or target range data presented. This limited coverage is typical for a mid-cap, high-growth, recently listed company like Planet Labs and implies higher volatility and less efficient price discovery, as institutional interest and research scrutiny are still developing. The recent institutional rating actions from firms like Morgan Stanley (Equal Weight), Needham (Buy), and Wedbush (Outperform) show maintained bullish or neutral stances, but without a quantifiable consensus target, the implied upside or downside from the current price cannot be calculated, increasing investment uncertainty.
Bulls vs Bears: PL Investment Factors
The bull case, driven by accelerating 41% revenue growth, powerful AI/defense catalysts, and improving operational metrics, currently holds stronger evidence due to the concrete fundamental momentum and transformative partnerships. However, the bear case presents a formidable counter-argument centered on an extreme valuation of 25x sales that demands perfection, deep ongoing losses, and high susceptibility to speculative sentiment. The single most important tension in the investment debate is whether the company's explosive growth trajectory and path to profitability can sustainably justify its peak historical valuation before any execution misstep or sector sentiment shift triggers a severe multiple compression.
Bullish
- Explosive Revenue Growth & Momentum: Q4 FY2026 revenue grew 41.05% YoY to $86.82M, accelerating from prior quarters and demonstrating strong top-line momentum. Sequential quarterly revenue increased from $66.27M to $86.82M over the fiscal year, indicating consistent demand and execution.
- Transformative AI & Defense Catalysts: Recent news highlights a transformative AI partnership with NVIDIA and a massive new defense contract, positioning Planet Labs for accelerated growth in high-value markets. A government-ordered data halt is viewed as a bullish signal confirming deep, revenue-securing national security partnerships.
- The Q4 operating margin improved to -41.47% from -80.50% a year ago, showing significant progress on cost control. Furthermore, the company generated positive TTM free cash flow of $56.41M, a critical milestone suggesting it is moving toward funding operations internally.
- Powerful Technical Uptrend: The stock is in a sustained uptrend with a 1-year price change of +1001.49% and a 6-month gain of +174.35%, significantly outperforming the SPY. It trades at 88% of its 52-week range from $3.38 to $41.71, indicating strong momentum and investor conviction.
Bearish
- Extreme Valuation at Peak Multiples: The stock trades at a trailing PS ratio of 24.98x, near the top of its observable historical range (from as low as 0.97x in early 2024). This extreme multiple prices in flawless execution of hyper-growth and leaves no room for disappointment.
- Heavy Dependence on Sentiment & Speculation: Recent news suggests the stock surge is partly driven by pure investor sentiment around the SpaceX IPO, not underlying business improvements. With a beta of 1.833, the stock is 83% more volatile than the market and highly vulnerable to a sentiment shift or sector rotation.
- Persistent, Deep Losses: The company remains deeply unprofitable, with a Q4 net loss of -$152.46M and a net margin of -175.6%. Return on Equity is catastrophically negative at -131.01%, reflecting significant losses eroding shareholder equity.
- Leveraged Balance Sheet: The debt-to-equity ratio of 2.45 indicates a leveraged capital structure, which increases financial risk, especially for a company still burning cash on an operating basis. While the current ratio of 1.65 shows adequate liquidity, high debt amplifies downside risk if growth stalls.
PL Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 1-year price change of +1001.49% and a 6-month gain of +174.35%. With a current price of $36.90, the stock is trading near the top of its 52-week range, approximately 88% of the way from its 52-week low of $3.38 to its high of $41.71, indicating strong momentum but also potential overextension and vulnerability to a pullback. Recent momentum remains robust but shows signs of consolidation; the stock gained +20.16% over the past month and +47.78% over the past three months, significantly outpacing the SPY's returns of +9.98% and +4.14%, respectively, though the 1-month gain is a deceleration from the explosive 3-month move, suggesting a potential pause or digestion of gains. Key technical support is anchored at the 52-week low of $3.38, though more immediate support likely resides near recent consolidation levels around $34-$35, while resistance is clearly defined at the 52-week high of $41.71. A decisive breakout above $41.71 would signal a continuation of the powerful uptrend, while a breakdown below the $34 support could indicate a deeper correction. The stock exhibits high volatility with a beta of 1.833, meaning it is approximately 83% more volatile than the broader market, which investors must account for in position sizing and risk management, especially given the stock's +972.45% relative strength versus the SPY over the past year.
Beta
1.91
1.91x market volatility
Max Drawdown
-29.0%
Largest decline past year
52-Week Range
$3-$43
Price range past year
Annual Return
+1006.4%
Cumulative gain past year
| Period | PL Return | S&P 500 |
|---|---|---|
| 1m | +26.8% | +7.7% |
| 3m | +92.0% | +9.7% |
| 6m | +277.5% | +11.3% |
| 1y | +1006.4% | +27.3% |
| ytd | +110.9% | +9.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PL Fundamental Analysis
Revenue growth is accelerating dramatically, with Q4 FY2026 revenue reaching $86.82 million, representing a year-over-year growth rate of 41.05%. This marks a significant acceleration from the prior-year Q4 revenue of $61.55 million, and the multi-quarter trend shows sequential quarterly revenue increases from $66.27M (Q1) to $73.39M (Q2) to $81.25M (Q3) to $86.82M (Q4), indicating strong, consistent top-line momentum. The company remains unprofitable on a net income basis, posting a Q4 net loss of -$152.46 million, though the gross margin of 54.17% is healthy and has shown stability, ranging between 52% and 57% over recent quarters. The operating margin of -41.47% in Q4, while deeply negative, represents a significant improvement from the -80.50% EBIT margin in the year-ago quarter, signaling progress on the path toward profitability. The balance sheet shows a debt-to-equity ratio of 2.45, indicating a leveraged capital structure, but liquidity appears adequate with a current ratio of 1.65. The company generated positive free cash flow on a TTM basis of $56.41 million, a critical improvement that suggests it is moving toward funding operations internally. However, the return on equity is deeply negative at -131.01%, reflecting the significant net losses relative to shareholder equity, and the return on assets is -5.86%, indicating inefficient use of assets to generate profits at this stage of growth.
Quarterly Revenue
$86822000.0B
2026-01
Revenue YoY Growth
+0.41%
YoY Comparison
Gross Margin
+0.54%
Latest Quarter
Free Cash Flow
$56409000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PL Overvalued?
Given the company's negative net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 24.98x, while the forward PS ratio implied by analyst revenue estimates is not directly calculable from the provided data, but the extreme forward P/E of -1640.0 highlights the market's expectation for significant future earnings growth to justify the current sales multiple. The stock trades at a substantial premium to typical industrials, but direct industry average multiples are not provided in the data for comparison. Historically, the stock's valuation has expanded enormously alongside its price surge. The current PS ratio of 24.98x is near the top of its observable historical range from the provided data, which shows PS ratios as low as 0.97x in early 2024 and 8.06x in April 2024, before the recent re-rating. Trading near historical valuation highs suggests the market is pricing in highly optimistic expectations for sustained hyper-growth, margin expansion, and market dominance, leaving little room for execution missteps.
PE
-31.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -21x~-3x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-83.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. Planet Labs operates with significant leverage (debt-to-equity of 2.45) and despite generating positive TTM FCF of $56.4M, it posted a Q4 net loss of -$152.5M, indicating it remains dependent on external capital and growth to justify its valuation. The company's return on equity of -131% highlights extreme inefficiency in generating profits from shareholder capital. Revenue concentration risk is mitigated by diverse applications, but the path to sustained profitability is unproven and any deceleration from the current 41% growth rate would severely pressure the stock.
Market & Competitive Risks are elevated. The stock's valuation at a PS ratio of 24.98x is at a historical peak, creating immense compression risk if growth expectations are not met. The stock's beta of 1.83 signals it is highly sensitive to broader market moves and sector sentiment. Recent news explicitly ties part of the stock's surge to the SpaceX IPO narrative, a speculative driver that could reverse. Competitive disruption from larger players like SpaceX entering adjacent markets or technological shifts poses a long-term threat.
Worst-Case Scenario involves a simultaneous failure: growth decelerates sharply post the initial defense contract surge, the AI partnership fails to materialize into significant monetization, and a broader market downturn triggers a flight from speculative, high-multiple stocks. This could lead to a rapid derating toward its pre-re-ration valuation levels. A realistic downside could see the stock fall to its 52-week low of $3.38, representing a potential loss of over -90% from the current price of $36.90. A more measured bear case, considering improved fundamentals, might see a pullback to the $20-$25 range (down -32% to -46%), aligning with support levels from early 2026.
FAQ
The key risks are: 1) Valuation Compression: The primary risk is the extreme PS ratio of 24.98x collapsing if growth slows, which could lead to severe price declines. 2) Execution & Profitability: The company is still deeply unprofitable (Q4 net loss of -$152.5M) and must prove it can reach sustainable profits. 3) Sentiment & Volatility: With a beta of 1.83 and news tying its moves to speculative sector events like the SpaceX IPO, the stock is highly vulnerable to sentiment shifts. 4) Financial Leverage: A debt-to-equity ratio of 2.45 increases financial risk if operational performance weakens.
Our 12-month outlook presents three scenarios. The Base Case (50% probability) sees the stock consolidating between $30 and $40 as it digests gains, assuming revenue growth stabilizes around 30-35%. The Bull Case (25% probability) targets $45 to $55, requiring flawless execution on AI/defense contracts and achieving operating profitability. The Bear Case (25% probability) warns of a drop to $15-$25 if growth disappoints and sector sentiment sours. The base case is most likely, implying limited near-term upside from the current $36.90 but significant potential volatility in both directions.
Based on traditional metrics, PL appears significantly overvalued. It trades at a trailing Price-to-Sales ratio of 24.98x, which is near the top of its own historical range and exceptionally high for any industry. The forward P/E is meaningless at -1640 due to losses. This valuation implies the market expects sustained hyper-growth above 40%, rapid margin expansion to profitability, and dominant market capture. Compared to its own history (PS as low as 0.97x in 2024), it is trading at a massive premium. The stock is priced for perfection, leaving it vulnerable to de-rating on any stumble.
PL is a compelling but risky investment at its current price. For aggressive growth investors comfortable with extreme volatility (beta 1.83) and binary outcomes, the accelerating 41% revenue growth and transformative AI/defense catalysts are attractive. However, the stock trades at a peak valuation of 25x sales, pricing in near-perfect execution. The lack of analyst price targets adds uncertainty. It could be a good buy on a significant pullback (e.g., below $30) for long-term holders, but at $36.90, the risk/reward is balanced, making it more suitable for a watchlist than a new core position.
PL is unsuitable for short-term trading or income investors due to its high volatility, lack of dividends, and speculative nature. It is a pure long-term growth story stock, best suited for investors with a minimum 3-5 year horizon who can withstand dramatic price swings. This timeframe is necessary to see if the company can convert its technological lead and partnerships into sustained profitability and justify its current valuation. The high beta of 1.833 means it will likely be much more volatile than the market over any short period, making it a poor candidate for short-term bets.